Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates

In this episode of MEDcast, expert neurologists delve into anti-CD20 disease modifying therapies (DMTs) in MS. They assess the correlation between clinical observations and immunological processes in MS patients, and also examine the role of the Epstein Barr virus in MS.